Blogg

Position Statement: Inclusion of Pregnant and Lactating Populations in Research

An Official Position Statement of the Society for Women’s Health Research POSITION In line with our mission to ensure women’s […]

SWHR Urges FDA OWH to Prioritize Inclusion of Pregnant Women in Clinical Trials

SWHR signed on to a comment letter from the Coalition to Advance Maternal Therapeutics (CAMT) regarding the inclusion of pregnant […]

SWHR Recommendations to FDA OWH on Strategic Priorities

SWHR submitted comments on the U.S. Food and Drug Administration (FDA) Office of Women’s Health’s strategic priorities. SWHR celebrates the […]

SWHR Comments to NAM on COVID-19 Vaccine Allocation Framework

SWHR provided comments in response to the National Academy of Medicine (NAM) “Discussion Draft of the Preliminary Framework for Equitable […]

SWHR Recommendations to FDA for PDUFA Reauthorization for FY 2023-27

SWHR provided comments as a follow-up to the U.S. Food and Drug Administration (FDA) public meeting regarding the proposed recommendations […]

SWHR Feedback to NIH on Improving Biomedical Animal Research

SWHR provided comments to the National Institutes of Health (NIH) Advisory Committee to the Director Working Group on Enhancing Rigor, […]

SWHR Comments to NIA on Alzheimer’s Research Gaps and Opportunities

SWHR Endorses AHRQ Funding Bill for Research on Critical Pandemic Health System Issues

SWHR signed on to a letter urging Speaker Nancy Pelosi (D-CA) and House Minority Leader Kevin McCarthy (R-CA) to endorse H.R. […]

SWHR Comments to NIDA on Strategic Plan for FYs 2021-2025

SWHR provided input to the National Institute on Drug Abuse (NIDA) on its Strategic Plan Outline for Fiscal Years (FYs) […]

SWHR Thanks HHS for Renewal of Public Health Emergency Declaration for COVID-19

SWHR and 90 other stakeholders thanked Department of Health and Human Services (HHS) Secretary Alex Azar for renewing the public […]